Expression of cell proliferation index (Ki-67) and EMT biomarkers of E-cadherin/Vimentin, which was detected by qRT-PCR and IHC, indicated that Neferine treatment significantly depressed HCC EMT phenotype and cell proliferation in xenograft tumor (Fig. 7c,d). Here, CDH1 is linked to hepatocellular carcinoma.